Tag Archives: Watson Pharmaceuticals

Goldman Sachs (GS) Cuts Watson Pharmaceuticals (NYSE:WPI) to “Neutral” From Buy – TEVA, MYL, ENDP, WPI,

Posted on January 12, 2013 by Geoff Noir

Goldman Sachs Group, Inc (NYSE:GS) shattered Watson Pharmaceuticals, Inc (NYSE:WPI) from Buy to Neutral and shattered the price forecasts in the range of $100.00 to $96.00.

Goldman Sachs stated that they downgrade Watson Pharmaceuticals from Buy to Neutral and cut …

Posted in Latest Headlines, Services | Tagged Endo Health Solutions, ENDP, MYL, Mylan, NASDAQ:ENDP, NASDAQ:MYL, NYSE:TEVA, NYSE:WPI, TEVA, Teva Pharmaceutical, Watson Pharmaceuticals, WPI | Comments Off

Emergent Biosolutions (NYSE:EBS) Issues FY 2012 Results; Revenue Misses Estimates – WPI, MYL, PPHM, VVUS, BSX, ILMN, SQNM, UNH

Posted on January 7, 2013 by Thomas Vedder

Emergent BiosolutionsInc (NYSE:EBS) on Monday reported its preliminary fiscal year 2012 financial results, projecting revenues slightly lower than Wall Street analysts’ forecasts. Biopharmaceutical Company also offered 2013 revenue outlook lower than forecasts.

The company projects net income in the range …

Posted in Healthcare, Latest Headlines | Tagged Boston Scientific, BSX, EBS, Emergent Biosolutions, Illumina, ILMN, MYL, Mylan, NASDAQ:ILMN, NASDAQ:MYL, NASDAQ:PPHM, NASDAQ:SQNM, NASDAQ:VVUS, NYSE:BSX, NYSE:EBS, NYSE:UNH, NYSE:WPI, Peregrine Pharmaceuticals, PPHM, Sequenom, SQNM, UNH, UnitedHealth, Vivus, VVUS, Watson Pharmaceuticals, WPI | Comments Off

Coronado Biosciences (NASDAQ:CNDO) Picks Harlan Weisman as New Chairman and Chief Executive – ABT, BIIB, PFE, HLF, MRK, VVUS, WPI, HEB

Posted on January 2, 2013 by Geoff Noir

Coronado Biosciences Inc (NASDAQ:CNDO) reported on Wednesday that the company has appointed Harlan Weisman as its new chairman and chief executive officer.

Harlan Weisman recently worked for Johnson & Johnson (NYSE:JNJ), where he held numerous posts, and before that he …

Posted in Healthcare, Latest Headlines | Tagged Abbott Laboratories, ABT, BIIB, BiogenIdec, CNDO, Coronado Biosciences, HEB, HemispherxBioPharma, Herbalife, HLF, Merck, MRK, NASDAQ:BIIB, NASDAQ:CNDO, NASDAQ:VVUS, NYSE:ABT, NYSE:HLF, NYSE:MRK, NYSE:PFE, NYSE:WPI, NYSEAMEX:HEB, PFE, Pfizer, Vivus, VVUS, Watson Pharmaceuticals, WPI | Comments Off

FDA Thumbs Up for Johnson & Johnson (NYSE:JNJ) Drug Sirturo – JNJ, MYL, WPI, GSK

Posted on January 2, 2013 by Geoff Noir

United States Food and Drug Administration approved Johnson & Johnson (NYSE:JNJ), one of the world’s biggest health-care conglomerate, medicine to treat a form of resistant tuberculosis that is uncommon in the United States but rising worldwide.

Johnson & Johnson’s drug, …

Posted in Healthcare, Latest Headlines | Tagged GlaxoSmithKline, GSK, JNJ, Johnson, MYL, Mylan, NASDAQ:MYL, NYSE:GSK, NYSE:JNJ, NYSE:WPI, Watson Pharmaceuticals, WPI | Comments Off

AMAG Pharmaceuticals (NASDAQ:AMAG) Submits SNDA for Feraheme Injection to FDA – AMAG, WPI, MRK, ARNA, MNKD, HLF, PFE, BSX

Posted on December 24, 2012 by Geoff Noir

AMAG Pharmaceuticals, Inc (NASDAQ:AMAG) reported on Monday that it has submitted a supplemental new medicine application or sNDA to the Food and Drug Administration for Feraheme Injection.

The sNDA proposes growth of signs for the Ferahame, or ferumoxytol, injection for …

Posted in Healthcare, Latest Headlines | Tagged AMAG, AMAG Pharmaceuticals, arena, ARNA, Boston Scie, BSX, Herbalife, HLF, MannKind, Merck, MNKD, MRK, NASDAQ:AMAG, NASDAQ:ARNA, NASDAQ:MNKD, NYSE:BSX, NYSE:HLF, NYSE:MRK, NYSE:PFE, NYSE:WPI, PFE, Pfizer, Watson Pharmaceuticals, WPI | Comments Off

Teva Pharmaceutical (NASDAQ:TEVA) Tumbles to Four Week Low – TEVA, WPI, NVS, PRX

Posted on May 29, 2012 by Thomas Vedder

Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) tumbled to a fourth week lowest level in New York and marked its biggest losing streak since November, as the company guidance lowers spurred Piper Jaffray & Co. to advocate investors keep away from …

Posted in Latest Headlines | Tagged NASDAQ:TEVA, Novartis, NVS, NYSE:NVS, NYSE:PRX, NYSE:WPI, Par Pharmaceutical, PRX, TEVA, Teva Pharmaceutical, Watson Pharmaceuticals, WPI | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.